Braintree Laboratories, Inc. v. Breckenridge Pharmaceuticals, Inc.

Case Number: 1:12-cv-06851-AJN (Dkt. 69)

Judge Nathan approved the parties’ proposal to maintain the case on administrative hold pending completion of proceedings in the Braintree v. Novel matter in New Jersey district court, to which the Federal Circuit recently remanded that case for claim construction of the term “clinically significant electrolyte shifts” and for additional factual findings to determine whether the composition covered by Novel’s ANDA product infringes under the new claim construction. Link to order placing the matter on administrative hold.

 

 

Topics:  ANDA, Patent Infringement, Patent Litigation, Patents, Pharmaceutical, Pharmaceutical Patents

Published In: Administrative Agency Updates, Civil Procedure Updates, Intellectual Property Updates, Science, Computers & Technology Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Robins, Kaplan, Miller & Ciresi L.L.P. | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »

CONNECT

Founded in 1938, Robins, Kaplan, Miller & Ciresi L.L.P. is a litigation firm that serves clients –... View Profile »


Follow Robins, Kaplan, Miller & Ciresi L.L.P.:

Reporters on Deadline